by The global metagenomic sequencing market offers solutions in areas such as human microbiome research, environmental remediation, industrial applications, drug discovery, epidemiology and agriculture. Metagenomic sequencing provides access to genetic information of uncultured microbes in microbial communities, assisting in better understanding of microbial diversity and functions. The approach offers crucial insights for health issues from antibiotics resistance to microbiome-related conditions.
The Global Metagenomic Sequencing Market Size Is Estimated To Be Valued At US$ 1.41 Bn In 2024 And Is Expected To Exhibit A CAGR Of 17.% Over The Forecast Period 2024-2031.
Key Takeaways
Key players operating in the global metagenomic sequencing market are Illumina, QIAGEN, Thermo Fisher Scientific, Oxford Nanopore Technologies, BGI Group, Perkinelmer, GENEWIZ, Macrogen, Zymo Research, Diversigen, Microsynth AG, Baseclear, MR DNA (Molecular Research), Eurofins Scientific, Novogene Corporation, Nugen Technologies, Takara Bio, Swift Biosciences, New England Biolabs, And Cosmosid.
The increasing adoption of genomic methodologies in clinical diagnostics and drug discovery is expected to boost market demand. Various research studies analyzing human microbiome are being conducted to better understand roles of microbes in metabolic and immune disorders using metagenomic sequencing approaches.
The market is witnessing expansion in regions such as Asia Pacific and Latin America due to growing R&D investments by pharmaceutical and biotechnology players in these areas. Several market players are focusing on strengthening their geographic presence through collaborations with regional research institutes.
Market Key Trends
Non-targeted or whole metagenomic shotgun sequencing is gaining traction as it provides access to both coding and non-coding sequences. Researchers are increasingly leveraging this technique to sequence all genetic material from a microbiome sample without relying on prior knowledge about composition of microbes. This helps gain novel biological insights. Continuous reduction in genome sequencing costs is also supporting wider adoption of whole metagenomic shotgun sequencing approaches.
Porter’s Analysis
Threat Of New Entrants: Low startup costs and technical expertise create low barriers to entry, but major companies have established brand recognition and R&D capabilities.
Bargaining Power Of Buyers: Individual consumers have limited bargaining power, but large pharmaceutical and biotech companies can negotiate on volume.
Bargaining Power Of Suppliers: A few key scientific instrument and reagent suppliers exist, allowing them to influence prices.
Threat Of New Substitutes: New genome sequencing technologies constantly emerge but established technologies have significant adoption.
Competitive Rivalry: Intense competition between major players to develop new applications and offerings and reduce costs further.
North America accounts for the largest share of the global metagenomic sequencing market, driven by ongoing R&D initiatives and increasing healthcare expenditure. Asia Pacific is poised to grow at the fastest CAGR during the forecast period due to rising biotech and pharma research in China, Japan, and India coupled with improving healthcare infrastructure and investment. Europe holds a significant market share owing to large genome centers and growing focus on precision medicine in the UK and Germany.
The metagenomic sequencing market in the Middle East and Africa remains in the development phase with steady growth expected over the next decade as more countries prioritize healthcare modernization initiatives. Latin America demonstrates high potential as genomic research collaborations increase between the US and countries like Brazil and Mexico. Chile in particular is emerging as a hub for biotech investment and clinical trials in the region.
What are the key data covered in this Global Metagenomic Sequencing Market report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Global Metagenomic Sequencing Market’s growth between 2024 and 2031.
:- Accurate calculation of the size of the Global Metagenomic Sequencing Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behavior
:- Global Metagenomic Sequencing Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Global Metagenomic Sequencing Market vendors
FAQ’s
Q.1 What are the main factors influencing the Global Metagenomic Sequencing market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Global Metagenomic Sequencing Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Global Metagenomic Sequencing market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
- Source: CoherentMI, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
